Kidney Function Following Left Ventricular Assist Device Implantation: An Observational Cohort Study

Area of Science:

• Cardiology
• Nephrology
• Medical Devices

Background:

• Nearly half of heart failure patients have co-existing chronic kidney disease (CKD).
• Left ventricular assist device (LVAD) implantation can improve kidney function, but not in all patients.
• Lack of kidney function improvement after LVAD is linked to poorer outcomes.

Purpose of the Study:

• To identify preimplantation factors that predict changes in kidney function after LVAD implantation.
• To understand which patient characteristics are associated with improved estimated glomerular filtration rate (eGFR) post-LVAD.

Main Methods:

• Single-center observational study of consecutive patients undergoing LVAD implantation.
• Analysis of 48 preimplantation variables including demographic, clinical, laboratory, hemodynamic, and echocardiographic data.
• Univariable and multivariable linear regression models were used to assess predictors of eGFR change.

Main Results:

• Among 131 patients, 75% showed improved eGFR at 1 month post-LVAD.
• Younger age, absence of diabetes mellitus (DM), lower baseline eGFR, and higher levels of certain liver and kidney biomarkers predicted 1-month eGFR improvement.
• In multivariable analysis, younger age, lower eGFR, and absence of DM were independently associated with 1-month eGFR increase.

Conclusions:

• Preimplantation factors like younger age, lower eGFR, and absence of DM are associated with improved kidney function at 1 month after LVAD.
• Predicting significant eGFR changes beyond 1 month using preimplantation variables is limited.
• Further research is needed to fully understand long-term kidney function changes post-LVAD.